Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

NCT04748471 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Prevention of COVID19

Interventions

BIOLOGICAL: mRNA-1273

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]